Last Updated on January 8, 2024 by The Health Master
Pharma major Dr Reddy’s Laboratories Ltd said it has launched its generic Methylprednisolone Sodium Succinate for injection, indicated for various conditions including arthritis, blood disorders and severe allergic reactions, in the US market.
The injection is the generic equivalent of SOLU-MEDROL and has been approved by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.
Dr Reddy’s Methylprednisolone Sodium Succinate for Injection is supplied in 40 mg/vial, 125 mg/vial single-dose vials, each carton containing 25 vials and 500 mg and 1 gm multi-dose vial each carton containing 1 vial, it added.
Citing IQVIA Health data, the company said the SOLU-MEDROL brand and its generic versions had US sales of approximately USD 144 million for the most recent twelve months ended February 2022.
Certain Products recalled due to Microbial Contamination
USFDA approves Cell Therapy for earlier lymphoma
Drug Recall: IDArubicin Hydrochloride Injection recalled due to this reason
USFDA gives 13 observations to Lupin
Govt further extends timeline to apply for slots under PLI scheme
CDSCO panel gives nod to Roche for Anticancer Drug Entrectinib Capsules
Nutraceuticals Regulations 2022 to encourage Pharma Industry
Telangana to fill posts of 18 Drug Inspectors, 442 Pharmacists and 15 junior Analysts
NPPA updated price lists: Download
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
